Long-Term Monitoring After Heart Valve Replacement
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
Recruiting
Observational Study
Aortic Stenosis
Atrial Fibrillation New Onset
Heart Block
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Kansas City Heart Rhythm Research Foundation · Other
Who this trial is looking for
This trial is looking for adults with severe aortic stenosis who have had a specific heart procedure and developed new heart rhythm issues. Participants will be monitored over a long period to assess their heart health.
Are You a Good Fit for This Trial?
You may be able to join if
- I am over 18 years old.
- I have severe aortic stenosis.
- I have undergone trans-catheter aortic valve implantation (TAVI).
- I have new heart rhythm issues detected after the procedure.
- I have had a long-term monitor implanted for these issues.
You may not be able to join if
- I need a pacemaker due to serious heart block after TAVI.
- I have an existing heart device implanted.
- I cannot have a subcutaneous implanted device due to my medical condition.
- I am currently pregnant.
- I do not want to sign consent to participate.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the Long term Evaluation of Cardiac Arrhythmias after Transcatheter Aortic Valve Implantation (LOCATE) Registry is to perform long-term ambulatory monitoring of patients with severe aortic stenosis who undergo trans-catheter aortic valve implantation (TAVI) and develop new onset conduction system abnormalities post-procedure that do not require urgent permanent pacemaker (PPM) impla…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients \> 18 years of age with severe aortic stenosis that undergo TAVI for severe aortic stenosis that develop any one of the following conduction system abnormalities on the immediate post procedural or post operative ECG and have undergone ILR implantation for long-term m…
Contacts